NCT02795234

Brief Summary

The aim of this study is to detect antibodies to vitamin D in the serum at Different Groups of patients and healthy volunteer. A second goal is to find the relation between Vitamin D Antibody and Vitamin D level.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2016

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2016

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

June 5, 2016

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 10, 2016

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2017

Completed
Last Updated

June 10, 2016

Status Verified

June 1, 2016

Enrollment Period

1 year

First QC Date

June 5, 2016

Last Update Submit

June 9, 2016

Conditions

Vitamin D Deficiency

Outcome Measures

Primary Outcomes (1)

  • Presence of Anti Vitamin D Antibodies in Blood Sample

    1 year

Study Arms (2)

Participants with Vitamin D deficiency

OTHER

Blood sample, venous blood, about 10 ml will be drawn from participants and tested for the presence of Vitamin D antibodies

Other: Blood samples

Participants with sufficient Vitamin D Level

OTHER

Blood sample, venous blood, about 10 ml will be drawn from participants and tested for the presence of Vitamin D antibodies

Other: Blood samples

Interventions

Blood samplesOTHER
Participants with Vitamin D deficiencyParticipants with sufficient Vitamin D Level

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients treated in Meir Medical Center
  • Data on serum vitamin D values
  • years old
  • Both sexes
  • Patient hereby declare that he\\she agree to participate the clinical trial

You may not qualify if:

  • Patient refuses to sign Informed Consent.
  • Patients without vitamin D values

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Vitamin D Deficiency

Interventions

Blood Specimen Collection

Condition Hierarchy (Ancestors)

AvitaminosisDeficiency DiseasesMalnutritionNutrition DisordersNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Study Officials

  • reut ohanah

    Meir Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Yair levy, MD

CONTACT

: 972-09-7472592levy.yair@clalit.org.il

Yael Eizikovits, SC

CONTACT

972-09-7471936yael.eizikovits@clalit.org.il

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Internal Medicine

Study Record Dates

First Submitted

June 5, 2016

First Posted

June 10, 2016

Study Start

June 1, 2016

Primary Completion

June 1, 2017

Study Completion

June 1, 2017

Last Updated

June 10, 2016

Record last verified: 2016-06